Elihu H. Estey
0000-0002-0987-8077
Publication & Citation Trends
Publications
1,033 total
Intensive Re-Induction Chemotherapy Followed by Early Allogeneic Hematopoietic Cell Transplant for Relapsed/Refractory High-Grade Myeloid Neoplasms.
Cited by 0
Semantic Scholar
Acknowledgment of Reviewers 2021
Cited by 0
Semantic Scholar
Age at Diagnosis and Patient Preferences for Treatment Outcomes in AML: A Discrete Choice Experiment to Explore Meaningful Benefits OA
Cited by 28
Semantic Scholar
Quantifying Patient Preferences for Treatment Outcomes in AML: A Discrete-Choice Experiment OA
Cited by 5
Semantic Scholar
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel PDF
Cited by 5,805
OpenAlex
Phase I Trial of Targeted Alpha-Particle Therapy with Actinium-225 (225Ac)-Lintuzumab and Low-Dose Cytarabine (LDAC) in Patients Age 60 or Older with Untreated Acute Myeloid Leukemia (AML)
Cited by 40
Semantic Scholar
The treatment-related mortality score is associated with non-fatal adverse events following intensive AML induction chemotherapy OA
Cited by 13
Semantic Scholar
Management of older or unfit patients with acute myeloid leukemia OA
Cited by 93
Semantic Scholar
Research Topics
Acute Myeloid Leukemia Research
(780)
Acute Lymphoblastic Leukemia research
(249)
Chronic Myeloid Leukemia Treatments
(175)
Myeloproliferative Neoplasms: Diagnosis and Treatment
(119)
Neutropenia and Cancer Infections
(117)
Affiliations
University of Iowa
Houston Methodist
Michael E. DeBakey VA Medical Center
Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa
Seattle Cancer Care Alliance